Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 11 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 11642354

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted
  2. US 11629122

    Linkers for antibody drug conjugates

    The Board of Regents of the University of Texas System · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  3. US 11612580

    Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions

    The Board of Regents of the University of Texas System · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted
  4. US 11603365

    Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  5. US 11602551

    Use of inosine for the treatment of t-reg deficiency

    The Board of Regents of the University of Texas System · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  6. US 11597774

    Antibody variable domains and antibody constructs

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  7. US 11597916

    Nicotine degrading enzyme variants

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  8. US 11597707

    CGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  9. US 11591579

    Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  10. US 11590085

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  11. US 11594135

    Methods of CD40 activation and immune checkpoint blockade

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  12. US 11591319

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  13. US 11576883

    L-DOPA microbiome therapy

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  14. US 11576889

    Methods of identifying and treating patients with HIF-2 inhibitor resistance

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  15. US 11565027

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  16. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  17. US 11548945

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  18. US 11542229

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11542486

    Human kynureninase enzyme variants having improved pharmacological properties

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  20. US 11534463

    Nucleic acids encoding kynurenine depleting enzymes

    The Board of Regents of the University of Texas System · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  21. US 11529314

    Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents

    The Board of Regents of the University of Texas System · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  22. US 11525002

    Human PD-L1 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  23. US 11517633

    Production of Lu-177 and other radionuclides via hot atom capture on nanostructured carbon

    The Board of Regents of the University of Texas System · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  24. US 11518800

    Mutations that drive VH4 antibody autoreactivity

    The Board of Regents of the University of Texas System · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted